{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T08:05:17Z","timestamp":1785917117659,"version":"3.56.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.drugalcdep.2017.08.001","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T20:30:07Z","timestamp":1504211407000},"page":"56-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Maternal buprenorphine treatment and infant outcome"],"prefix":"10.1016","volume":"180","author":[{"given":"Lauren M.","family":"Jansson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha L.","family":"Velez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystle","family":"McConnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Tuten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendree","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Van L.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Gandotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine","family":"Millio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet A.","family":"DiPietro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2017.08.001_bib0005","series-title":"Multiple Regression: Testing and Interpreting Interactions","author":"Aiken","year":"2017"},{"key":"10.1016\/j.drugalcdep.2017.08.001_bib0010","series-title":"Do We Really Need Zero-Inflated Models?","author":"Allison","year":"2012"},{"key":"10.1016\/j.drugalcdep.2017.08.001_bib0015","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000210042","article-title":"Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome","volume":"15","author":"Bakstad","year":"2009","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.drugalcdep.2017.08.001_bib0020","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0022-3476(79)80734-9","article-title":"A simplified score for assessment of fetal maturation of newly born infants","volume":"95","author":"Ballard","year":"1979","journal-title":"J. Pediatr."},{"key":"10.1016\/j.drugalcdep.2017.08.001_bib0025","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.drugalcdep.2004.03.012","article-title":"Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure","volume":"75","author":"Choo","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.08.001_bib0030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/00223890802634175","article-title":"The analysis of count data: a gentle introduction to poisson regression and its alternatives","volume":"91","author":"Coxe","year":"2009","journal-title":"J. Pers. Assess."},{"key":"10.1016\/j.drugalcdep.2017.08.001_bib0035","doi-asserted-by":"crossref","first-page":"h2102","DOI":"10.1136\/bmj.h2102","article-title":"Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study","volume":"350","author":"Desai","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2017.08.001_bib0040","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.1651-2227.2008.00838.x","article-title":"Neonatal outcome of 58 infants exposed to maternal buprenorphine in utero","volume":"97","author":"Hytinantii","year":"2008","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.drugalcdep.2017.08.001_bib0045","series-title":"IBM SPSS Statistics for Windows, Version 24.0","author":"IBM Corp. Released","year":"2015"},{"key":"10.1016\/j.drugalcdep.2017.08.001_bib0050","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0740-5472(96)00070-0","article-title":"Pregnancy and addiction: a comprehensive care model","volume":"13","author":"Jansson","year":"1996","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2017.08.001_bib0055","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5055\/jom.2009.0006","article-title":"The opioid-exposed newborn: assessment and pharmacologic management","volume":"5","author":"Jansson","year":"2009","journal-title":"J. Opioid. Manag."},{"key":"10.1016\/j.drugalcdep.2017.08.001_bib0060","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.drugalcdep.2011.10.003","article-title":"Pregnancies exposed to methadone, methadone and other illicit substances, and poly-drugs without methadone: a comparison of fetal neurobehaviors and infant outcomes","volume":"122","author":"Jansson","year":"2012","journal-title":"Drug Alcohol Depend."},{"issue":"529","key":"10.1016\/j.drugalcdep.2017.08.001_bib0065","first-page":"e1","article-title":"Maternal buprenorphine treatment and fetal neurobehavioral development","volume":"216","author":"Jansson","year":"2017","journal-title":"AJOG"},{"key":"10.1016\/j.drugalcdep.2017.08.001_bib0070","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure","volume":"363","author":"Jones","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2017.08.001_bib0075","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.drugalcdep.2013.11.006","article-title":"Neonatal outcomes and their relationship to maternal buprenorphine dose during pregnancy","volume":"134","author":"Jones","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.08.001_bib0080","first-page":"604","article-title":"Correlations of maternal buprenorphine dose, buprenorphine and metabolite concentrations in meconium with neonatal outcomes","volume":"84","author":"Kacinko","year":"2008","journal-title":"Clin. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2017.08.001_bib0085","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1360-0443.2012.04038.x","article-title":"Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication","volume":"107","author":"Kaltenbach","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.08.001_bib0090","doi-asserted-by":"crossref","first-page":"799","DOI":"10.15585\/mmwr.mm6531a2","article-title":"Incidence of neonatal abstinence syndrome \u2014 28 states, 1999\u20132013","volume":"65","author":"Ko","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2017.08.001_bib0095","doi-asserted-by":"crossref","first-page":"e547","DOI":"10.1542\/peds.2013-3524","article-title":"Neonatal abstinence syndrome","volume":"134","author":"Kocherlakota","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.drugalcdep.2017.08.001_bib0100","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1080\/08897077.2016.1146649","article-title":"Factors associated with buprenorphine versus methadone use in pregnancy","volume":"37","author":"Krans","year":"2016","journal-title":"Subst. Abuse"},{"key":"10.1016\/j.drugalcdep.2017.08.001_bib0105","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40748-017-0044-2","article-title":"An overview of available drugs for management of opioid abuse during pregnancy","volume":"3","author":"Laslo","year":"2017","journal-title":"Mat. Health Neonatal Perinatol."},{"key":"10.1016\/j.drugalcdep.2017.08.001_bib0110","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.drugalcdep.2005.10.001","article-title":"Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenorphine substitution","volume":"82","author":"Lejeune","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.08.001_bib0115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","article-title":"The fifth edition of the addiction severity index: historical critique and normative data","volume":"9","author":"McLellan","year":"1992","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2017.08.001_bib0120","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/hup.1224","article-title":"Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women","volume":"26","author":"Metz","year":"2011","journal-title":"Human Psychopharmacol. Clin. Exp."},{"key":"10.1016\/j.drugalcdep.2017.08.001_bib0125","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3122\/jabfm.2011.02.100155","article-title":"Observational; study of buprenorphine treatment of opioid-dependent pregnant women in a family medicine residency: reports on maternal and infant outcomes","volume":"24","author":"O\u2019Connor","year":"2011","journal-title":"J. Am. Board Fam. Med."},{"key":"10.1016\/j.drugalcdep.2017.08.001_bib0130","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000441220","article-title":"Maternal buprenorphine dose at delivery and its relationship to neonatal outcomes","volume":"22","author":"O\u2019Connor","year":"2016","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.drugalcdep.2017.08.001_bib0135","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2012.3951","article-title":"Neonatal abstinence syndrome and associated health care expenditures: united States, 2000\u20132009","volume":"307","author":"Patrick","year":"2012","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.drugalcdep.2017.08.001_bib0140","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1542\/peds.2014-3299","article-title":"Prescription opioid epidemic and infant outcomes","volume":"135","author":"Patrick","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.drugalcdep.2017.08.001_bib0145","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1186\/s40064-016-2576-8","article-title":"Predictors of neonatal abstinence syndrome in buprenorphine exposed newborn: can cord blood buprenorphine metabolite levels help?","volume":"5","author":"Shah","year":"2016","journal-title":"Springer Plus"},{"key":"10.1016\/j.drugalcdep.2017.08.001_bib0150","series-title":"Guidelines for the Identification and Management of Substance Use and Substance Use Disorders in Pregnancy","author":"World Health Organization","year":"2014"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617304295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617304295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T12:04:58Z","timestamp":1750853098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871617304295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":30,"alternative-id":["S0376871617304295"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.08.001","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maternal buprenorphine treatment and infant outcome","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}